High Prevalence of Extended-Spectrum Beta Lactamases among Salmonella enterica Typhimurium Isolates from Pediatric Patients with Diarrhea in China by Yu, Fangyou et al.
High Prevalence of Extended-Spectrum Beta Lactamases
among Salmonella enterica Typhimurium Isolates from
Pediatric Patients with Diarrhea in China
Fangyou Yu
1, Qiang Chen
2, Xiaojun Yu
2, Qiaoqiao Li
3, Baixing Ding
4, Lehe Yang
3, Cong Chen
4, Zhiqiang
Qin
5, Chris Parsons
5, Xueqing Zhang
1, Jinwei Huang
6, Yun Luo
7, Liangxing Wang
3*, Jingye Pan
4*
1Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China, 2Department of Laboratory Medicine, Jiangxi Provincial
Children Hospital, Nanchang, China, 3Department of Respiratory Medicine, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China, 4Department of
Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China, 5Division of Infectious Diseases, Department of Medicine, Medical
University of South Carolina, Charleston, South Carolina, United States of America, 6Department of Laboratory Medicine, Lishui Center Hospital, Lishui, China,
7Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
Abstract
We investigated the extended-spectrum beta lactamases among 62 Salmonella enterica Typhimurium isolates recovered
from children with diarrhea in a Chinese pediatric hospital. A large proportion of S. enterica Typhimurium isolates were
resistant to multiple antimicrobial agents, including ampicillin (90.3%), tetracycline (80.6%), trimethoprim/sulfamethoxazole
(74.2%), chloramphenicol (66.1%), cefotaxime (27.4%). Forty-nine (79.0%) of S. enterica Typhimurium isolates were positive
for blaTEM-1b and resistant to ampicillin. Thirteen S. enterica Typhimurium isolates (21.0%) were positive for blaCTX-M-1-group
and blaCTX-M-9-group, and all isolates harboring blaCTX-M genes were positive for ISEcp1. Two main clones (PFGE type A and D)
accounted for nearly 70% of S. enterica Typhimurium isolates, and 7 CTX-M-producing isolates belonged to PFGE type D.
Collectively, our data reveal multi-drug resistance and a high prevalence of extended spectrum beta lactamases among S.
enterica Typhimurium isolates from children in China. In addition, we report the first identification of blaCTX-M-55 within
Salmonella spp. Our data also suggest that clonal spread is responsible for the dissemination of S. enterica Typhimurium
isolates.
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Introduction
Nontyphoidal Salmonella species, particularly Salmonella enterica
Typhimurium, are the most common bacterial pathogens causing
enteric infections among pediatric patients [1]. Antimicrobial
agents are required for treating invasive infections caused by
Salmonella spp., and third-generation cephalosporins are commonly
used to treat invasive infections or severe diarrhea because of their
pharmacodynamic properties and the low prevalence of resistance
[2]. However, increasing resistance to cephalosporins has been
reported worldwide for Salmonella spp., particularly S. enterica
Typhimurium [3,4,5,6,7]. Resistance to broad-spectrum cephalo-
sporins is often due to production of various plasmid-mediated ß-
lactamases, especially CTX-M-type extended-spectrum b-lacta-
mases (ESBLs) [4,7,8,9]. Cefotaximases (CTX-M), comprised of
five major CTX-M groups (1, 2, 8, 9, and 25), are associated with
higher levels of hydrolytic activity against cefotaxime relative to
ceftazidime and are distributed among a wide range of bacteria
with clinical significance over a wide geographic area [10].
In China, a low prevalence of resistance to third-generation
cephalosporins has been reported among Salmonella spp., especially
those isolated from pediatric patients [11,12]. The aim of the
present study was to investigate the frequency of antimicrobial
resistance and cephalosporin resistance genes within S. enterica
isolates from pediatric inpatients with diarrhea in a Chinese
pediatric hospital. However, high prevalence of broad spectrum
cephalosporin resistance and ESBLs were found among S. enterica
Typhimurium isolates from children in China.
Materials and Methods
Bacterial isolates
From May 2007 to March 2009, a total of 62 S. enterica
Typhimurium isolates were collected from stool samples collected
from 62 inpatients aged ranging from 39 days to five years old with
diarrhea in Jiangxi provincial pediatric hospital in Nanchang,
China. S. enterica Typhimurium isolates were identified using
standard biochemical tests and commercial typing antiserum
according to the manufacturer’s instructions. O and H antigens
were characterized by slide agglutination with hyperimmune sera
(Chengdu Biotech, China) and the serotype was assigned
according to the Kauffmann-White scheme. Among 62 inpatients
included, 34 and 28 patients were male and female. The ages of
the patients were as follows: 39 days 21 year old, 37 patients; 1–2
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patients and 4–5 years old, 4 patients. The antimicrobial agents
used for treating the infections by S. enterica Typhimurium included
penicillin, azithromycin, amoxicillin/sulbactam, latamoxef, cefo-
perazone/sulbactam, ceftazidime, ampicillin/sulbactam, ceftria-
xone, cefazolin, ceftizoxime, and imipenem. Of 62 patients with
diarrhea, 7, 4, 4 and 2 patients suffered bronchitis, pharyngitis,
acute tonsillitis and meningitis, respectively. After treated by
antimicrobial agents, all patients were cured and left hospital.
Persistance of diarrhea ranged from 7 to 40 days. Addition to S.
enterica Typhimurium, Campylobacter spp, enteropathogenic Escherichia
coli and Shigella spp were not isolated from the stools of the patients
included. This study focused on bacterial, so ethics approval was
not needed according to the Ethics Committee of Wenzhou
Medical College’s regulatioans.
Antimicrobial susceptibility
Antimicrobial susceptibility was determined by the disk diffusion
method with 18 antimicrobial agents according to the criteria
recommended by the CLSI [13], including including cefotaxime
(30 mg), ceftazidime (30 mg), ampicillin (10 mg), aztreonam (30 mg),
cefaclor (30 mg), cefoxitin (30 mg), piperacillin plus tazobactam
(100/10 mg), imipenem (10 mg), meropenem (10 mg), chloram-
phenicol (30 mg), trimethoprim/sulfamethoxazole (1.25/23.75 mg),
tobramycin (10 mg), gentamicin (10 mg), amikacin (30 mg), tetra-
cycline (30 mg), nalidixic acid (30 mg), ciprofloxacin (5 mg), and
levofloxacin (5 mg). MICs for cefotaxime and ceftazidime, were
further determined by the agar dilution method in accordance
with CLSI guidelines [13]. Escherichia coli ATCC 25922 was used
as quality control strain for antimicrobial susceptibility testing.
Detection of resistance genes
Total DNA was extracted by boiling. Briefly, a fresh bacterial
colony was suspended in 150 mL of sterile distilled water and
boiled at 100uC for 10 minutes. After centrifugation at 15000 rpm
for 15 minutes at 4uC, the supernatant was removed and stored at
220uC for PCR assays. PCR and DNA sequencing were
performed for the detection of ESBL genes in all ampicillin-
resistant isolates with oligonucleotide primers previously described,
including those for blaTEM, blaSHV, blaCTX-M, blaVEB and
blaPER.genes [14,15]. All amplicon sequences were compared with
those in the GenBank nucleotide database (www.ncbi.nlm.nih.
gov/blast/). PCR mapping experiments using combinations of the
ISEcp1 forward primers and the blaCTX-M-1-group or blaCTX-M-9 group
reverse primers were performed to detect the flanking regions of
blaCTX-M-1-group and blaCTX-M-9-group genes.
Transfer of resistance genes
In order to determine whether cephalosporin resistance was
transferable in S. enterica Typhimurium isolates, a conjugation
experiment was carried out in Luria-Bertani broth with E. coli J53
as the recipient as previously described [16]. Transconjugants
were selected on tryptic soy agar plates containing sodium azide
(100 mg/mL) for counterselection and cefotaxime (30 mg/mL) for
plasmid-mediated cephalosporin resistance selection.
Pulsed-field gel electrophoresis (PFGE)
Chromosomal DNA was prepared from all S. enterica Typhi-
murium isolates and cleaved with 40 U XbaI. Electrophoresis was
performed on 1% agarose gels in 0.5 M Tris/borate/EDTA
buffer on a CHEF-Mapper XA PFGE system (Bio-Rad, Hercules,
CA) for 22 h at 14uC, with run conditions of 6 V/cm, a pulse
angle of 120u and pulse times from 5 to 20 s. A lDNA ladder
(Amersham Biosciences) was used to confirm molecular mass and
bands stained with ethidium bromide (0.5 mg/mL) prior to their
identification through photography under UV light. Comparison
of the PFGE patterns was performed with Bionumerics software
(Applied Maths, Sint-Martens-Latem, Belgium) using the Dice
Similarity coefficient. Clusters were defined as DNA patterns
sharing more than 85% similarity.
Results
Antimicrobial susceptibility
Of the 62 S. enterica Typhimurium isolates, 59 (95.2%) were
resistant to at least three antimicrobial agents, while only 2 (3.2%)
were susceptible to all antimicrobial agents tested. S. enterica
Typhimurium isolates tested were most commonly resistant to
ampicillin (90.3%, 56/62), followed by tetracycline (80.6%, 50/
62), trimethoprim/sulfamethoxazole (74.2%, 46/62) and chlor-
amphenicol (66.1%, 41/62). Seventeen (27.4%, 17/62) and 8 (8/
62, 12.9%) isolates were resistant to cefotaxime (MIC range from
64 to .256 mg/mL) and ceftazidime (MIC range from 32 to
.256 mg/mL), respectively. All ceftazidime-resistant isolates were
also resistant to cefotaxime. Twelve isolates (19.4%, 12/62) were
highly resistant to ciprofloxacin (MIC$4 mg/mL). The frequen-
cies of resistance and intermediate to other antimicrobial agents
among S. enterica Typhimurium isolates were as follows: cefoxitin,
8.1% (5/62) and 1.6% (1/62); aztreonam, 16.1% (10/62) and
12.9% (8/62); cefaclor, 35.5% (22/62) and 0; ampicillin/
sulbactam, 51.6% (32/62) and 25.8% (16/62); piperacillin/
tazobactam, 19.4% (12/62) and 51.6% (32/62); amikacin,
17.7% (11/62) and 41.9% (26/62); gentamicin, 51.6% (32/62)
and 6.5% (4/62); and tobramycin, 56.5% (35/62) and 17.7% (11/
62). All isolates were susceptible to imipenem and meropenem.
b-lactam resistance genes
Forty-nine (79.0%) of 62 S. enterica Typhimurium isolates were
positive for blaTEM and resistant to ampicillin. All blaTEM
amplicons were confirmed as blaTEM-1b by DNA sequencing.
Thirteen S. enterica Typhimurium isolates (21.0%, 13/62) were
positive for blaCTX-M-1-group and blaCTX-M-9-group genes (8 for
blaCTX-M-14, 3 for blaCTX-M-15, 1 for blaCTX-M-55, and 1 for both
blaCTX-M-14 and blaCTX-M-55). Characteristics of S. enterica Typhi-
murium isolates producing ESBLs were showed in Figure 1.
Among the 8 CTX-M-14- producing isolates with MICs
ranging from 128 to 256 mg/mL for cefotaxime, only one was
highly resistant to ceftazidime (128 mg/mL) whereas the other 7
exhibited reduced susceptibility to ceftazidime (2–8 mg/mL).
Three CTX-M-15- producing isolates with MICs ranging from
32to128 mg/mLforceftazidime werehighlyresistanttocefotaxime
(MIC.256 mg/mL). Two isolates harboring blaCTX-M-55 were
highly resistant to cefotaxime and ceftazidime (MICs.256 mg/
mL). All isolates harboring blaCTX-M genes were positive for ISEcp1.
Analysis of the flanking regions of blaCTX-M genes showed that
the insertion sequence ISEcp1 was located 48 bp, 45 bp or
42 bp upstream from blaCTX-M-15 (accession number GQ330540),
blaCTX-M-55 (accession number GQ456157) or blaCTX-M-14 (acces-
sion number GQ385325), respectively.
Transfer of antimicrobial resistance genes
Extended-spectrum cephalosporin resistance could be trans-
ferred by conjugation from seven ESBL-producing donors (two
isolates harboring blaCTX-M-15, six harboring blaCTX-M-14, and one
harboring both blaCTX-M-14 and blaCTX-M-55). Seven cephalosporin
resistance transconjugants were resistant to chloramphenicol and
trimethoprim/sulfamethoxazole and harbored blaTEM-1b.
ESBLs among S. enterica Typhimurium Isolates
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Ten different PFGE clusters were identified among the 62 S.
enterica Typhimurium isolates. PFGE types A, B, and D accounted
for 19.4% (12/62), 9.7% (6/62) and 50% (31/62) of these isolates,
respectively. Thirteen ESBLs-producing isolates distributed in six
FPGE clusters listed in Figure 1. Of the 8 CTX-M-14-producing
S. enterica Typhimurium isolates, 5, 2 and 1 belonged to PFGE type
D, B and I, respectively. Three CTX-M-15-producing isolates
belonged to three different PFGE types (F, G and H). One CTX-
M-55-producing isolate and both CTX-M-14 and CTX-M-55-
producing isolates belonged to PFGE type D.
Discussion
The majority of S. enterica Typhimurium isolates in our study
were resistant to multiple antimicrobial agents, indicating that
fewer antibiotics may be useful for treating S. enterica Typhimurium
infections. Carbapenems exhibit high antimicrobial activity
against S. enterica Typhimurium isolates in vitro in our studies.
The CLSI recommends that for fecal isolates of Salmonella and
Shigella spp., only ampicillin, fluoroquinolone, and trimethoprim/
sulfamethoxazole sensitivities should be reported routinely,
whereas for extraintestinal isolates of Salmonella spp., only
sensitivities to chloramphenicol and third-generation cephalospo-
rins should be reported [13]. However, S. enterica Typhimurium
resistance rates for ampicillin, trimethoprim/sulfamethoxazole
and chloramphenicol were very high (more than 60%) in our
studies. In addition, although no patient had received fluoroquin-
olones prior to isolation of Salmonella spp. from their stool, 48% and
19% of S. Typhimurium isolates exhibited low- or high-level
resistance to ciprofloxacin, respectively. Therefore, our data
suggest that ampicillin, trimethoprim/sulfamethoxazole, chloram-
phenicol and fluoroquinolones should be used with caution for the
treatment of S. enterica Typhimurium infections in the pediatric
population. ESBL- and AmpC-mediated resistance has been
reported for nontyphoidal Salmonella isolates in many geographic
areas [5,17,18,19]. However, reported resistance of nontyphoidal
Salmonella isolates to broad-spectrum cephalosporins remains low
[12,20,21]. In the study conducted in Wuhan, China using clinical
samples from children ages 0–3 years, only 7 of 221 (3.2%) S.
enterica isolates were resistant to ceftriaxone (10). In another study
from the Henan province, only 2.1% of S. enterica Typhimurium
patient isolates were resistant to ceftiofur over a 2-year timeframe
[11,12]. Relative to these studies, the rates of resistance to broad-
spectrum cephalosporins for S. enterica Typhimurium isolates in our
study was very high.
Broad-spectrum cephalosporins are commonly used to treat
serious Salmonella infections. ESBLs are the predominant cause of
resistance to broad- spectrum cephalosporins in Enterobacteria-
ceae, particularly E. coli and Klebsiella spp. Therefore, understand-
ing patterns and mechanisms for interspecies and intraspecies
transfer of ESBLs is of great interest. The TEM-, SHV- and CTX-
M-type ESBLs are the most widely distributed worldwide.
Published reports indicate that CTX-M-type ESBLs are the most
prevalent in China [22,23]. blaCTX-M-14 and blaCTX-M-15 genes
have been identified in S. enterica Typhimurium isolates from many
areas including China [4,7,11,12,24]. In the present study, CTX-
M-type ESBLs, mainly CTX-M-14, were detected in S. enterica
Typhimurium isolates, indicating that CTX-M-type ESBLs were
the predominant cause of resistance to broad-spectrum cephalo-
sporins for S. enterica Typhimurium isolates in our study. The
mobile genetic element ISEcp1, a single copy insertion sequence
responsible for mobilization of bla genes and identified upstream of
several blaCTX-M genes carried by E. coli and Klebsiella spp isolates,
was found in association with all of our isolates. We speculate that
the S. enterica Typhimurium isolates in China could have acquired
the blaCTX-M genes from E. coli and Klebsiella spp in the community,
and that subsequent spread of these genes among S. enterica
Typhimurium isolates may have occurred. Future epidemiologic
studies may confirm whether these genes were transmitted in this
or perhaps other sequences, and the potential clinical implications
of ESBL-mediated resistance for gastrointestinal and/or invasive
infections caused by S. Typhimurium.
blaCTX-M-55, which increases the catalytic efficiency against
ceftazidime, is a variant of the blaCTX-M-15 gene and previously
found only in E. coli and K. pneumonia spp. in China and Thailand
[25,26,27]. Interestingly, we found that two S. enterica Typhimur-
ium isolates with resistance to both cefotaxime and ceftazidine
harbored blaCTX-M-55, and one of these harbored both blaCTX-M-14
and blaCTX-M-55. To our knowledge, this is the first report of
blaCTX-M-55 in Salmonella spp. Recently, 24 (24.5%) of 98 E. coli
isolates recovered from pets in South China were found to harbor
blaCTX-M-55, among which 6 isolates harbored both blaCTX-M-14
and blaCTX-M-55 [25]. The partial DNA sequence of ISEcp1 found
45 bp upstream of blaCTX-M-55 in the single isolate in our study
harboring both blaCTX-M-14 and blaCTX-M-55 was 100% identical to
Figure 1. Characteristics of S. enterica Typhimurium isolates producing ESBLs. CTX: cefotaxime; CAZ: ceftazidime; SXT: trimethoprim/
sulfamethoxazole; TE: tetracycline; SAM: ampicillin plus sulbactam; AMP: ampicillin; CEC: cefaclor; TOB: tobramycin; CN: gentamicin; AMK: amikacin;
TZP: piperacillin plus tazobactam; C: chloramphenicol.
doi:10.1371/journal.pone.0016801.g001
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coli isolates from the pets in this study. We speculate that E. coli
which either colonize or cause clinically apparent infection in pets
may serve as a reservoir for blaCTX-M-14 and blaCTX-M-55 genes
and, ultimately, cause clinically apparent infections in pediatric
patients. Confirmation of this hypothesis, and the development of
subsequent clinical strategies for limited these infections, would
require additional comprehensive surveillance efforts among
communities in China and elsewhere.
In our study, two main clusters (PFGE types A and D) were
found, indicating that gastrointestinal infections in children were
caused mainly by clonally related S. enterica Typhimurium isolates
and clonal spread was responsible for the dissemination of S.
enterica Typhimurium. Because 5 isolates harboring blaCTX-M-14
genes and two isolates harboring blaCTX-M-55 genes belonged
to the same PFGE cluster (D), the spread of blaCTX-M-14 and
blaCTX-M-55 genes was also associated with clonal spread.
In conclusion, the present study demonstrates significant multi-
drug resistance among S.enterica Typhimurium within a pediatric
population in China, including a higher prevalence of broad-
spectrum cephalosporin resistance and expression of blaCTX-M
genes among S. enterica Typhimurium isolates than what has
previously been reported. Moreover, the present study is the first
report of the presence of blaCTX-M-55 genes in Salmonella spp.
Finally, our data suggest that clonal spread is responsible for the
dissemination of S. enterica Typhimurium isolates and blaCTX-M-14
genes in this population.
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